ORTHOPEDIATRICS CORP(KIDS)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

ORTHOPEDIATRICS CORP (KIDS) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores KIDS at 37.8/100 on a 32-signal composite quality model, placing it at rank #2,223 of 2,962 stocks — the bottom half of the AI-ranked universe. KIDS scores in the top quartile across revenue growth (79.3). Areas of concern include balance sheet strength (19.1) and profitability (19.7), which score below median versus the broader universe. Shareholder dilution risk is elevated at 19.8/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), ORTHOPEDIATRICS CORP reports quarterly revenue of $70.5M, net income of $-7.2M, free cash flow of $-3.1M. Top institutional holders of KIDS by reported 13-F value include BROWN ADVISORY, BlackRock, BRAIDWELL, based on the most recent SEC filings. KIDS trades on the Nasdaq exchange and files with the SEC under CIK 1425450. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate KIDS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ORTHOPEDIATRICS CORP directly from SEC EDGAR.